期刊文献+

^(18)F-FDG PET在结直肠癌中的临床应用价值 被引量:2

The applications of ^(18)F-FDG PET in colorectal carcinoma
暂未订购
导出
摘要 18F鄄FDGPET在结直肠癌原发、复发及转移的诊断中具有重要价值,特别是在结直肠癌的分期治疗方案的选择方面。结合CT、MRI和CEA(癌胚抗原)检测可以提高诊断的准确性。同时,18F鄄FDGPET在对结直肠癌的疗效监测以及评价手术效果方面也有比较重要的作用。 PET scanning in colorectal carcinoma has a definite clinical impact on identification of primary and metastatic tumor,especially on detection,staging,and administration of the recurrent colorectal cancer and liver metastases.In addition,combined with CT,MRI,CEA and other techniques,PET can improve accuracy in diagnosis.Meanwhile,it is also important to monitor curative effect of colorectal cancer.
作者 董爱生
出处 《国外医学(放射医学核医学分册)》 2004年第1期12-14,共3页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 ^18F-FDG PET 结直肠癌 临床应用 原发性肿瘤 肿瘤复发 肿瘤转移 诊断 positron emission tomography colorectal carcinoma 18 F-fluoro-deoxyglucose
  • 相关文献

参考文献15

  • 1Guillem JG, Puig-La CJ Jr, Akhursf T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18F-fluorodeoxyglucose positron emission tomography [J]. Dis Colon Rectum,2000, 43: 18-24.
  • 2Ruhlmann J, Schomburg A, Bender H, et al. Fluorode oxyglucose whole-body positron emission tomography in colorectal cancer patients studied in rourine daily practice [J].Dis Colon Rectum, 1997, 40:1195-1204.
  • 3Park KC, Schwimmer J, Shepherd JE, et al. Decision analysis for the cost-effective management of recurrent colorectal cancer[J]. Ann Surg, 2001, 233: 310-319.
  • 4Meta J, Seltzer M, Schiepers C, et al. Impact of 18F-FDG PET on managing patients with colorectal cancer: The referring physician's perspective[J]. J Nucl Med, 2001, 42:586-590.
  • 5Darius C, Desai MD, Emanuel E, et al. Positron emission tomography affects surgical management in recurrent colorectal cancer patients[J]. Ann Surg, 2003, 10:59-64.
  • 6Whiteford MH, Whitefor HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocareinoma of the colon and rectum[J].Dis Colon Rectum, 2000, 43: 759-770.
  • 7Bender H, Bangard N, Metten N, et al. Possible role of FDG PET the early predication of therapy outcome in liver metastases of colorectal cancer[J]. Hybridoma, 1999, 18(1):87-91.
  • 8Hung GU, Shiau YC, Tsai SC, et al. Value of 18F-FDGPET in the evaluation of recurrent colorectal cancer[J]. Anticancer Res, 2001, 21(2B): 1375-1378.
  • 9Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer[J]. Ann Surg, 1998,27: 319-323.
  • 10Zhuang H, Sinha P, Pourdehnad M, et al. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver [J].Nucl Med Commun, 2000, 21(9): 793-798.

同被引文献21

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部